Exclusion Of Diversity And Creativity Impedes Scientific Innovation

Scientific Innovation Author: Fred M. Cowan The "information age" with accompanying "big science" has emphasized data generation, analytical thinking, and specialization. This may have had the unfortunate consequence of segregating mainstream science from the novel and abstract ideas, often created at the margins of science, that stimulate rapid progress and invention. Has too narrow a focus on empirical phenomena slowed the innovations that benefit society and prove the utility of science?

Written byFred Cowan
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Scientific Innovation Author: Fred M. Cowan

The "information age" with accompanying "big science" has emphasized data generation, analytical thinking, and specialization. This may have had the unfortunate consequence of segregating mainstream science from the novel and abstract ideas, often created at the margins of science, that stimulate rapid progress and invention. Has too narrow a focus on empirical phenomena slowed the innovations that benefit society and prove the utility of science?

The perception that science has not sufficiently focused on the needs of society has surfaced among the lay population and elected officials, who ultimately control research funds. This is caused, in part, by false expectations that science would miraculously deliver mankind from disease, war, hunger, and so forth. However, with the current reality of strategic, results-oriented science as well as budget cuts, science can ill afford to revere dogma and maintain conventions that obstruct invention. This does not imply ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies